GSK Investigational Site

Newcastle, New South Wales 2300

1 studies enrolling now · 5 studies all time

What they study most

Bowel Dysfunction, Colonic Neoplasms, Constipation, Melanoma, Multiple Myeloma, Neoplasms, Colon

Studies at this site

• Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer — Recruiting now
• Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma — Completed
• Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma — Running, not enrolling
• A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma — Completed
• Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed